A key difference between SUMMIT and Novo Nordisk's STEP-HFpEF study of semaglutide is that it included hard cardiovascular outcomes as the primary endpoint. In contrast, Novo Nordisk's study ...

This marks a significant step for the company ... suffering from heart failure with preserved ejection fraction (HFpEF), a condition in which the heart muscles stiffen and reduce the amount ...

The next step will be the expected announcement of filing ... the confirmatory Phase III clinical trial of omecamtiv mecarbil and AMBER-HFpEF, the Phase II clinical trial of CK-586.

Bristol-Myers Squibb Company ( NYSE: BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference November 11, 2024 10:00 AM ET Samit Hirawat - EVP, Chief Medical Officer, Global Drug ...

Mikhail Kosiborod, MD, FACC The pivotal trials, STEP-HFpEF and STEP-HFpEF DM, were international, multicenter, double-blind, placebo-controlled trials in individuals with the obesity phenotype of ...

This month's cover story dives into the results from the pivotal STEP-HFpEF and STEP-HFpEF DM trials which have shown significant improvement in HF symptoms, physical capacity and weight loss. "It's ...

The Danish drugmaker, whose coffers have been swelled by rocketing sales of its diabetes and obesity therapies, said the deal is “an important step ... fraction (HFpEF), and anti-amyloid ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

The 2024 election is all hands on deck for American newsrooms. And student reporters are helping supply critical local news to communities across the country. The Center for Community News intends to ...

Nostalgia and modern technology will shine a light on an old school toy during a new pop-up coming to Santa Monica. The classic Lite-Brite toy is the inspiration for a new interactive pop-up ...

Could this be the week the San Francisco 49ers finally get Christian McCaffrey back on the field? McCaffrey, who has been battling Achilles tendinitis in both ankles, has yet to make his 2024 ...